NUOVI FARMACI ANTIEPILETTICI

Translated title of the contribution: New antiepileptic drugs

V. Loreto, A. Mariniello, S. Striano

Research output: Contribution to journalArticle

Abstract

Over 20% of epileptic patients are resistant to treatment with the currently available antiepileptic drugs (AEDs). Only for a subset of such drug-resistant (DR) patients brain surgery is suitable. Several new compounds have been recently introduced in therapy, decreasing significantly the number of DR patients. Other putative AEDs are in advanced stage of clinical evaluation. The present review briefly deals with data available in the literature on felbamate, gabapentin, lamotrigine and vigabatrin. Furthermore, the authors report their own data regarding the use of vigabatrin either as 'add-on therapy' in patients with DR partial epilepsy, either as monotherapy in newly diagnosed patients with symptomatic or cryptogenic partial epilepsy.

Translated title of the contributionNew antiepileptic drugs
Original languageItalian
Pages (from-to)945-966
Number of pages22
JournalNeurologia Psichiatria Scienze Umane
Volume14
Issue number6
Publication statusPublished - 1994

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology

Fingerprint Dive into the research topics of 'New antiepileptic drugs'. Together they form a unique fingerprint.

  • Cite this

    Loreto, V., Mariniello, A., & Striano, S. (1994). NUOVI FARMACI ANTIEPILETTICI. Neurologia Psichiatria Scienze Umane, 14(6), 945-966.